STERIS Reports Strong FY26: Revenue Hits $5.94B, EPS Jumps 28% to $7.93
STE is trading near its 52-week low of $195.14 (9.0% above the low).
Summary
STERIS plc reported strong full-year 2026 financial results, with revenue reaching $5.94 billion and diluted EPS increasing by 27.9% to $7.93. This news summarizes the company's 10-K filing from earlier today, confirming the robust performance hinted at in prior May 11th reports. The significant growth in revenue and EPS, driven by volume, pricing, and favorable foreign exchange, underscores solid operational execution across all major segments.
At the time of this announcement, STE was trading at $212.73 on NYSE in the Life Sciences sector, with a market capitalization of approximately $20.9B. The 52-week trading range was $195.14 to $269.44. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.